10x Genomics认证服务商计划（CSP）

晶能生物技术（上海）有限公司（简称"晶能生物"）是博爱新开源医疗科技股份有限公司全资子公司（股票代码：300109）。我们拥有一个集成的CRO服务平台，包括单细胞研究、高通量测序和基因芯片服务。我们专注于为科技服务和医疗检测提供整体解决方案。

安诺优达基因科技（北京）有限公司总部位于北京，在浙江省义乌设有南方中心。是中国基因组行业的知名企业，也是亚洲一流的医学基因组中心。安诺优达获得了以下荣誉称号：国家发改委首批基因检测技术应用示范中心，国家高新技术企业、"十三五"时期第一批北京生物医药产业跨越发展工程（G20工程）企业、北京科技研发机构、北京专利试点机构、北京知识产权示范组织、北京企业技术中心、北京经济技术开发区企业创新集群中国最具投资价值的公司。北京知识产权示范组织。 安诺优达专注于新一代基因组技术在人类健康、医学和生命科学研究方面的工业应用。在测序设备中建立了优良的产品体系和品牌效应、分子诊断试剂、医学检测和研究、科研服务、基因大数据和云平台服务，形成覆盖上、中、下游业务的整体产业链布局和强大的生物IT产业服务能力。公司赢得了众多合作伙伴的积极评价。

贝瑞基因为制药和学术界提供临床和研究基因组服务。我们经验丰富的团队使用10x Genomics平台提供多种单细胞服务，包括10x Genomics单细胞RNA-Seq、10x Genomics单细胞ATAC-Seq、10x Genomics单细胞V(D)J、10x Genomics单细胞CNV、10x Genomics Visium空间基因表达解决方案。我们的快速周转、互动项目咨询和数据分析支持使您专注于您的研究。把单细胞测序交给贝瑞基因的测序专家，让您的发现更快!

百奥智汇致力于单细胞基因组学和生物信息学在人类疾病诊断和治疗上的应用，发现新的治疗和诊断靶标、创新治疗策略，创建人类疾病的精准图谱。目前，我们开发了快速、高效的单细胞组学分析方法，建立了国际上先进的单细胞组学数据库和交互性单细胞数据展示平台，拥有多项单细胞生物信息技术专利。

北京博奥晶典生物技术有限公司是一家行业领先的生命科学公司，致力于对医疗保健整体解决方案进行开发和商业化。公司为从生物医学研究人员到医疗保健专业人员的多元化客户群提供全面的优质产品组合。产品包括创新和广泛的微阵列和微流体芯片及相关仪器、软件和数据库，用于基础和转化研究、药物开发、临床诊断、生物安全、食品安全和分子育种。

上海贝晶生物技术有限公司为香港基因集团（Gene Group Holdings）全资子公司。公司位于上海闵行区紫竹高新区，致力于科学研究和临床应用领域的产品研发、生产、销售、服务及技术推广。 公司在张涛博士的带领下，秉承了基因集团20多年生命科学领域内专业的服务理念和经验，组建专业的研发和市场技术服务团队，专注于追踪生命科技前沿，整合先进的技术平台和生物信息学资源，为国内外生命科学领域用户提供各项技术及实验服务，尤其是基因组学前沿的生物芯片，高通量基因分型，高通量测序应用以及相关生物信息学分析等方面。除了服务于科学研究，也为在医学、药物、农林业等产业化应用方面提供系统解决方案。

The University of Michigan Advanced Genomics Core’s mission is to facilitate research in cutting-edge fields of genetics and genomics by implementing complex technologies. Chief among these is “next generation” sequencing (NGS), which has revolutionized research in virtually all biological fields in the past decade. By housing NGS and companion genomic technologies in a single facility, we provide a centralized expertise in advanced methods that enables all researchers to effectively exploit them for making scientific discoveries.

The AGCT Core enables investigators with little experience in sample preparation, quality control or analysis to interrogate the genome. To facilitate this, we have developed general but complete wet-lab and bioinformatics analysis pipelines to accommodate standard needs and enable most genomewide investigations. For more sophisticated or custom designs, we work actively in collaboration with other Cedars-Sinai cores and resources to facilitate investigations.

BRC-Seq is a Next-Generation Sequencing Core that sets out to assist researchers with generating high-quality data and providing full workflows to investigators with little experience in sample preparation, quality control, or informatic analysis. We've grown our expertise around Illumina Sequencing and 10x Genomics Single Cell & Visium Spatial Sequencing and continue to implement new applications into our standard services. Located at the Biomedical Research Centre at the University of British Columbia, we strive to make the power of sequencing available to all researchers at UBC and beyond.

Diamond Age partners with fast-moving biotech and pharmaceutical companies to drive innovation through bioinformatics. They develop and provide custom solutions for the most challenging problems in computational biology. They can also act as a one-stop shop, analyzing existing data (proprietary or public) and helping to answer scientific and strategic questions.   They are led by founder Eleanor Howe, a computational biologist and expert in transcriptional profiling and pathway analysis. Each bioinformatician at Diamond Age has over a decade of experience in the field as well as advanced degrees in life sciences.

Established in 2000, DNA Link, Inc. has been maintaining its high-quality NGS services globally. As one of the few NGS labs who maintain CSP-level services for all major NGS platforms, DNA Link has provided breakthrough solution for many challenging genomic analysis projects. From sample preparation to bioinformatics support, DNA Link provides end-to-end solution for any genomic research projects.

Geninus, Inc. spin-out of Samsung Genome Institute, provides comprehensive genetic analysis services to empower precision medicine. Their database has both genetic and clinical information to enable clinicians and researchers to promote public health. They lead next generation precision medicine by constructing clinical-genetic information big data. The core proprietary technology is powered by Samsung Genome Institute and is continuously developing by collaborating with Samsung Medical Center and many renowned research institutes around the world.

The Spatial and Single Cell Genomics Platform (S2GP) at Genome Institute of Singapore provides the local research community, with easy access to state-of-the-art single cell capabilities, multi-omics expertise and consultation. The Centre offers multiple 10X and Fluidigm workflows as fee-for-service (ScRNAseq, ScATACseq, Immune profiling (TCR, BCR) and spatial  transcriptome profiling). GIS-S2GP has been functioning as a user friendly, collaborative catalyst in Singapore’s single cell space.

The Genomics Core Facility at the Icahn Institute for Data Science and Genomic Technology and Department of Genetics and Genomic Sciences is a CLIA-certified laboratory, which houses both our basic and translational genomics research. Our researchers leverage cutting-edge technologies and next-generation sequencing capabilities for research and clinical applications. We help investigators and clinicians analyze samples, identify genetic variants contributing to disease risk, and reveal complex mechanisms involved in human disease.

The Imagine Single-Cell platform assists customers from the design of an experiment up to the analyses of single-cell data, with of course single-cell libraries generation and sequencing. The platform will propose all the solutions and protocols commercialized by 10x genomics, with strong expertise in Single-cell gene expression, CITE-seq, ATAC-seq, Immune profiling (TCR, BCR) and the emerging spatial transcriptomic. The Imagine Single-Cell platform is hosted by the Imagine Institute, a leading centre for research, care and teaching on genetic diseases in Europe.

Immunai combines the latest advances in single cell genomics, bioinformatics and artificial intelligence to measure the immune system at high resolution, at unprecedented scale. Our platform pairs these precise immune measurements with relevant clinical context for 1000-patient multi-arm immuno-oncology clinical trials to generate data and insights on mechanisms of action and resistance, biomarkers, combination design, cell therapy product heterogeneity, and more. We partner with leading biopharmas and academic groups to apply our technology and data to drive the development of more effective immunotherapies, and bring these therapies to market more quickly and reliably.

One of our main tasks is to ensure maintenance and transfer of the advanced technological details of DNA sequencing to the future generations. Our additional endeavor is to acquire constantly introduced/modified techniques and methods as well as to develop new techniques and methods of our own. Throughout these activities we aim to create and run a system in which the techniques and methods we use will be offered to scientists in industrial, academic and governmental sectors. Partly based on the royalty we obtain from our clients, we will be able to keep the system continuously running.→ In order to return to the society the knowhow we have acquired through our genomic and genetic analysis over the past 20 years at Kazusa DNA Research Institute, we are planning to provide the society with a system in which advanced technologies for genomic/genetic analysis that require a rather heavy initial investment may be accommodated for the society. In addition to offering commonly used analytical methods within the system, we are happy to announce that users of the system may ask us to help them in performing difficult tasks such as, for example, sequencing degraded or small amounts of DNA/RNA, etc. Until today, using a variety of analytical facilities with sophisticate functions, we have performed a large number of genomic/genetic analyses requested by scientists from industrial, academic and governmental sectors. We will continue to collaborate with scientists of public research institutions as well as those of private sectors by providing them with technical helps and/or contract-based analyses of their samples.

KOTAI Biotechnologies, Inc. is a company offering state-of-the-art research capability to researchers in academia and industries. Our strong research basis has been established through collaborative research projects with top clinical researchers on various disease areas in Japan for years. We are not just a simple service provider but your research partner with deep understandings of your needs.

Novogene is a leading provider of genomic services and solutions with cutting edge NGS and bioinformatics expertise and the largest sequencing capacity in the world. The company offers 10x Genomics Single Cell RNA-Seq, 10x Genomics Single Cell ATAC-Seq, 10x Genomics Single Cell V(D)J, and 10x Genomics Visium Spatial Gene Expression Solution using 10x Genomics platforms. We are world-leading in NGS services, with thousands of employees and multiple locations across the globe. We are proud to be able to support your research by generating high-quality, publication-ready data in a rapid time-frame. Reach out to us and we will get back to you shortly.

The PMGC is proud to offer one of the largest technology and service portfolios available. We are dedicated to helping you get the most out of your experiment, and will work with you to identify the optimal platform to answer your question.

Proteona is a precision medicine company in Singapore and Germany that is pioneering the use of single cell genetics, genomics and proteomics to improve clinical outcomes in cancer. Using a combination of commercial and proprietary single cell assays with our MapCell suite of bioinformatics tools, Proteona provides a comprehensive sample to answer service that enables users to spend less time trying to understand their data and more time impacting medicine.

Q² Solutions, a leading clinical trial laboratory services organization that provides end-to-end services for Single-cell gene expression, Immune profiling (TCR, BCR), high-throughput sequencing, gene expression profiling and genotyping studies. Our professionals have real-world insight into regulations, customs and sample requirements to help navigate our customer’s products through a global, local or regional trial.

In addition, Q² Solutions provides bioanalytical, vaccines, flow cytometry, anatomic pathology, immunoassay, companion diagnostics and central laboratory services.

Shanghai Baygene Biotechnologies Company Limited is invested by the Hong Kong Gene Group Holdings. They are located in Zizhu National High-Tech Park, Minhang District, Shanghai. They are always committed to scientific and clinical products research and development, manufacturing, sales, technique services and promotion.

Under the leadership of Dr. Cheung To, endowed with professional service philosophy and expertise of Gene Group in the fields of life science, Shanghai Baygene has established professional teams of development and market tech services. Concentrating on keeping up with the frontier of life science, integrating the advanced technology platform and bioinformatics resources, Shanghai Baygene provides a variety of technologies and services for users in the life science field both domestic and abroad, especially Gene-Chip、High-Throughput Genotyping, High-Throughput Sequencing applications and bioinformatics analysis. Apart from the scientific research, Shanghai Baygene also provides solutions for applications in medical science, pharmaceuticals and agriculture and forestry.

Combining expertise across Newcastle University’s core facilities of Genomics, Bioimaging, Bioinformatics and the HDBR, we pleased to be able to offer our SPARTAN service - Spatially Resolved Transcriptomics At Newcastle. Using Visium technology from 10x Genomics, we take your tissue samples through the entire Visium process beginning with sample preparation right the way through to delivery of your results in an easy to interpret and visualise form, ready for immediate analysis. Additionally, human developmental material can be made available for analysis to support your research project.

The Stanford Genomics formerly Stanford Functional Genomics Facility (SFGF) provides services for high-throughput sequencing, single-cell assays, gene expression and genotyping studies utilizing microarray and real-time PCR, and related services to researchers within the Stanford community and to other institutions.

Welgene Biotech provides ISO17025-certificated services on the high-throughput technology platforms such as microarray and next generation sequencing, and drives these technologies into clinical testing or commodities. Welgene continues to co-work with researchers to establish more core technologies, products and business opportunities.